SANUWAVE Health, Inc.
SNWVNASDAQHealthcare● Active
$14.55
$-0.21(-1.42%)
Market Cap$125115101
P/E Ratio—
52W High$46.585
52W Low$14.54
SANUWAVE Health, Inc. (SNWV) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SNWV · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
-$0.17
Est. -$0.14 · -21.4%
Revenue
$0.01B
Est. $0.01B · +0.2%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
▼ Miss EPS
SNWV reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 14, 2026 | -$0.03 | — | — | — | $0.01B | — |
| ▼ Q2 FY2026 | May 12, 2026 | -$0.14 | -$0.17 | -21.4% | $0.01B | $0.01B | +0.2% |
| ▼ Q1 FY2026 | Mar 26, 2026 | $0.17 | $0.03 | -82.3% | $0.01B | $0.01B | +1.1% |
| ▲ Q4 FY2025 | Nov 7, 2025 | $0.32 | $0.46 | +43.8% | $0.01B | $0.01B | -13.4% |
| ▲ Q3 FY2025 | Aug 8, 2025 | -$0.09 | $0.01 | +111.1% | $0.01B | $0.01B | -18.8% |
| — Q2 FY2025 | May 9, 2025 | — | -$0.66 | — | $0.01B | — | — |
| — Q1 FY2025 | Mar 20, 2025 | — | -$1.21 | — | $0.01B | — | — |
| — Q4 FY2024 | Nov 7, 2024 | — | -$6.49 | — | $0.01B | — | — |
Q3 FY2026
Aug 14, 2026
EPS Actual
—
EPS Est.
-$0.03
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026Miss
EPS Actual
-$0.17
EPS Est.
-$0.14
EPS Surpr.
-21.4%
Revenue
$0.01B
Q1 FY2026
Mar 26, 2026Miss
EPS Actual
$0.03
EPS Est.
$0.17
EPS Surpr.
-82.3%
Revenue
$0.01B
Q4 FY2025
Nov 7, 2025Beat
EPS Actual
$0.46
EPS Est.
$0.32
EPS Surpr.
+43.8%
Revenue
$0.01B
Q3 FY2025
Aug 8, 2025Beat
EPS Actual
$0.01
EPS Est.
-$0.09
EPS Surpr.
+111.1%
Revenue
$0.01B
Q2 FY2025
May 9, 2025
EPS Actual
-$0.66
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q1 FY2025
Mar 20, 2025
EPS Actual
-$1.21
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q4 FY2024
Nov 7, 2024
EPS Actual
-$6.49
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.67 | $0.67 | $0.67 | 1 |
| Q3 FY2027 | $0.55 | $0.55 | $0.55 | 1 |
| Q2 FY2027 | $0.37 | $0.37 | $0.37 | 1 |
| Q1 FY2027 | $0.29 | $0.29 | $0.29 | 1 |
| Q4 FY2026 | $0.07 | $0.07 | $0.07 | 1 |
| Q3 FY2026 | $0.01 | $0.01 | $0.01 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 12, 2026 | -21.4% | $16.00 | $16.04 | +0.25% |
| ▼ Q1 FY2026 | Mar 26, 2026 | -82.3% | $19.93 | $18.85 | -5.42% |
| ▲ Q4 FY2025 | Nov 7, 2025 | +43.8% | $26.41 | $31.08 | +17.68% |
| ▲ Q3 FY2025 | Aug 8, 2025 | +111.1% | $34.32 | $39.76 | +15.85% |
| — Q2 FY2025 | May 9, 2025 | — | $31.55 | $30.10 | -4.60% |
| — Q1 FY2025 | Mar 20, 2025 | — | $31.71 | $32.00 | +0.91% |
| — Q4 FY2024 | Nov 7, 2024 | — | $18.55 | $19.40 | +4.58% |
| — Q3 FY2024 | Aug 12, 2024 | — | $6.07 | $5.77 | -4.94% |
Q2 FY2026+0.25%
Report Date
May 12, 2026
EPS Beat/Miss
-21.4%
Price Before
$16.00
Price After
$16.04
Q1 FY2026-5.42%
Report Date
Mar 26, 2026
EPS Beat/Miss
-82.3%
Price Before
$19.93
Price After
$18.85
Q4 FY2025+17.68%
Report Date
Nov 7, 2025
EPS Beat/Miss
+43.8%
Price Before
$26.41
Price After
$31.08
Q3 FY2025+15.85%
Report Date
Aug 8, 2025
EPS Beat/Miss
+111.1%
Price Before
$34.32
Price After
$39.76
Q2 FY2025-4.60%
Report Date
May 9, 2025
EPS Beat/Miss
—
Price Before
$31.55
Price After
$30.10
Q1 FY2025+0.91%
Report Date
Mar 20, 2025
EPS Beat/Miss
—
Price Before
$31.71
Price After
$32.00
Q4 FY2024+4.58%
Report Date
Nov 7, 2024
EPS Beat/Miss
—
Price Before
$18.55
Price After
$19.40
Q3 FY2024-4.94%
Report Date
Aug 12, 2024
EPS Beat/Miss
—
Price Before
$6.07
Price After
$5.77
Avg Beat Reaction+16.77%
Avg Miss Reaction-2.58%
Beat Rate2 / 8 quarters
Largest Move+17.68% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SNWV ends December
SANUWAVE Health, Inc. (SNWV) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $-0.17 — missing the analyst consensus of $-0.14 by -21.4%. The next SNWV earnings date is expected around September 1, 2026.
Each quarter, investors track SNWV earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SNWV revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SNWV's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SNWV earnings · 5 questionsSANUWAVE Health, Inc.'s next earnings report is expected around September 1, 2026. SNWV typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SNWV historically reports after market close (AMC).
SNWV earnings datewhen is SNWV earningsSNWV next earnings datewhen does SNWV report earningsSNWV earnings calendar
▸ Source: FMP · SANUWAVE Health, Inc. SEC filings · US GAAP · SANUWAVE Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026